HSP90 overexpression potentiates the B-cell receptor and fibroblast growth factor receptor survival signals in chronic lymphocytic leukemia cells.

Mahmud, Hasan; Mendez, Mariana; Mukhopadhyay, Bedabrata; Holter-Chakrabarty, Jennifer; Ghosh, Asish K

Mahmud, Hasan; Mendez, Mariana; Mukhopadhyay, Bedabrata; Holter-Chakrabarty, Jennifer; Ghosh, Asish K.

Afiliación

Mahmud H; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Mendez M; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Mukhopadhyay B; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Holter-Chakrabarty J; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Ghosh AK; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Oncotarget ; 11(22): 2037-2046, 2020 Jun 02.

Article en En | MEDLINE | ID: mdl-32547702

Palabras clave

BCR; CD79a; CLL; HSP90; PTPN22

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google